v3.25.2
Summary of equity attributable to Novartis AG shareholders (Details) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Disclosure of classes of share capital [line items]        
Equity at beginning of period $ 38,452 $ 39,756 $ 44,126 $ 46,750
Exercise of options and employee transactions, equity impact   (1)   (35)
Shares delivered to divested business employees, equity impact Sandoz   2   12
Taxes on treasury share transactions (2) (12) (33) 8
Dividends     (7,818) (7,624)
Net income 4,024 3,246 7,633 5,934
Other comprehensive income 1,988 205 3,029 (1,058)
Changes in non-controlling interests 2   2  
Equity at end of period 42,054 41,902 42,054 41,902
Net dividend paid     5,300 5,200
Withholding tax on the gross dividend     $ 2,500 $ 2,400
Equity attributable to owners of parent [member]        
Disclosure of classes of share capital [line items]        
Number of shares outstanding at beginning of period     1,975.1 2,044.0
Equity at beginning of period 38,369 39,675 $ 44,046 $ 46,667
Shares acquired to be cancelled     (48.8) (26.7)
Shares acquired for cancellation, equity impact     $ (5,350) $ (2,698)
Other share purchases     (1.6) (1.1)
Other share purchases, equity impact     $ (159) $ (115)
Exercise of options and employee transactions, equity impact   (1)   $ (35)
Equity-based compensation plans and employee transactions, shares     11.1 8.3
Equity-based compensation plans and employee transactions, equity impact     $ 557 $ 517
Shares delivered to divested business employees, equity impact Sandoz   2   12
Taxes on treasury share transactions (2) (12) (33) 8
Dividends     (7,818) (7,624)
Net income 4,041 3,246 7,647 5,934
Other comprehensive income $ 1,987 $ 207 3,027 (1,054)
Changes in non-controlling interests     1 (28)
Other movements     $ 67 $ 126
Increase decrease through transfers and other movements equity, shares     0.1 0.1
Number of shares outstanding at end of period 1,935.9 2,024.6 1,935.9 2,024.6
Equity at end of period $ 41,985 $ 41,733 $ 41,985 $ 41,733
Share capital        
Disclosure of classes of share capital [line items]        
Equity at beginning of period 766 793 793 825
Equity at end of period 766 793 766 793
Treasury shares        
Disclosure of classes of share capital [line items]        
Equity at beginning of period (19) (17) (53) (41)
Equity at end of period (33) (25) (33) (25)
Retained earnings        
Disclosure of classes of share capital [line items]        
Equity at beginning of period 39,839 43,834 46,561 49,649
Exercise of options and employee transactions, equity impact   (1)   (35)
Shares delivered to divested business employees, equity impact Sandoz   2   12
Taxes on treasury share transactions (2) (12) (33) 8
Dividends     (7,818) (7,624)
Net income 4,041 3,246 7,647 5,934
Changes in non-controlling interests     1  
Equity at end of period 41,527 45,836 41,527 45,836
Total value adjustments        
Disclosure of classes of share capital [line items]        
Equity at beginning of period (2,217) (4,935) (3,255) (3,766)
Other comprehensive income 1,987 207 3,027 (1,054)
Equity at end of period $ (275) $ (4,871) $ (275) $ (4,871)